SCHEMBL7790476

SCHEMBL7790476

CC(=O)N[C@H]1CC[C@H]([N]c2ccc(Cl)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
ATF4 P18848 1/20 0.42
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
EPHX1 P07099 3/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 2/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
MTNR1A P48039 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790009 0.80 NPC1 (0.52) EPHX1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL7790478 0.76 POLB (0.54) LMNAATF4PSEN1PSEN2APH1B
SCHEMBL7784542 0.76 SMN1; SMN2 (0.38) LMNANPC1CYP2C19SMN1; SMN2MAPT
SCHEMBL7784589 0.73 HTR3E (0.38) LMNAALDH1A1NPC1CYP2C19RAB9A
SCHEMBL24011508 0.71 EPHX1 (0.74) LMNAEPHX1POLBNPC1CYP2C9
SCHEMBL284319 0.70 ATM (0.56) EPHX1ALDH1A1POLBNPC1RAB9A
SCHEMBL50350 0.70
SCHEMBL7793305 0.70 PDE7A (0.41) LMNANPC1CYP2C19RAB9AMAPT
SCHEMBL284318 0.70 ATM (0.56) EPHX1ALDH1A1POLBNPC1RAB9A
SCHEMBL284342 0.70 ATM (0.56) EPHX1ALDH1A1POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed